NDC 58602-816 – Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold
Naproxen Sodium 220 mg/1; Pseudoephedrine Hydrochloride 120 mg/1 · Tablet, Extended Release · Oral
Product NDC58602-816
Product details
- Brand name
- Naproxen Sodium and Pseudoephedrine Hydrochloride Sinus and Cold
- Generic name
- Naproxen Sodium and Pseudoephedrine Hydrochloride
- Labeler
- Aurohealth LLC
- Dosage form
- Tablet, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA211360
- Marketed since
- June 1, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Nonsteroidal Anti-inflammatory Drug; alpha-Adrenergic Agonist
Active ingredients
- Naproxen Sodium 220 mg/1
- Pseudoephedrine Hydrochloride 120 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 58602-816-67 | 2 BLISTER PACK in 1 CARTON (58602-816-67) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Jun 1, 2022 |
| 58602-816-72 | 3 BLISTER PACK in 1 CARTON (58602-816-72) / 8 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Feb 12, 2025 |
| 58602-816-83 | 1 BLISTER PACK in 1 CARTON (58602-816-83) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK | Jun 1, 2022 |